We have made some major changes in the HCV Advocate Drug Pipeline in an effort to make it easier for us to update it, and we hope it will make it easier for our web audience to read and understand.
- The main section is devoted to Direct Acting Antivirals (DAA)—A quick reference guide makes it easier to see all the DAAs in development. In the DAA quick reference guide the drugs that are in phase 2, 3, or 4 of development will have the date the comments were updated. You can click on the DAA to take you to the actual updated comments.
- The non-DAA (general) drugs will be listed on another page with basic information—only general drugs that are in phase 3 or phase 4 studies will include comments.